Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia, v. 95, n. 2, 13 Jun.2023.